본문 바로가기
HOME> 논문 > 논문 검색상세

논문 상세정보

ACS chemical neuroscience v.8 no.1, 2017년, pp.178 - 185   SCIE
본 등재정보는 저널의 등재정보를 참고하여 보여주는 베타서비스로 정확한 논문의 등재여부는 등재기관에 확인하시기 바랍니다.

Neuroprotective Effect of a New 7,8-Dihydroxycoumarin-Based Fe2+/Cu2+ Chelator in Cell and Animal Models of Parkinson's Disease

Aguirre, Pabla (Biology Department, Faculty of Sciences, Universidad de Chile, Santiago 7800024, ); García-Beltrán, Olimpo (Facultad de Ciencias Naturales y Matemáticas, Universidad de Ibagué, Ibagué ); Tapia, Victoria (730001, ); Muñoz, Yorka (Biology Department, Faculty of Sciences, Universidad de Chile, Santiago 7800024, ); Cassels, Bruce K. (Biology Department, Faculty of Sciences, Universidad de Chile, Santiago 7800024, ); Núñez, Marco T. (Department of Chemistry, Faculty of Sciences, Universidad de Chile, Santiago 7800024, );
  • 초록  

    Disturbed iron homeostasis, often coupled to mitochondrial dysfunction, plays an important role in the progression of common neurodegenerative diseases such as Parkinson’s disease (PD). Recent studies have underlined the relevance of iron chelation therapy for the treatment of these diseases. Here we describe the synthesis, chemical, and biological characterization of the multifunctional chelator 7,8-dihydroxy-4-((methylamino)methyl)-2 H -chromen-2-one (DHC12). Metal selectivity of DHC12 was Cu 2+ ∼ Fe 2+ > Zn 2+ > Fe 3+ . No binding capacity was detected for Hg 2+ , Co 2+ , Ca 2+ , Mn 2+ , Mg 2+ , Ni 2+ , Pb 2+ , or Cd 2+ . DHC12 accessed cells colocalizing with Mitotracker Orange, an indication of mitochondrial targeting. In addition, DHC12 chelated mitochondrial and cytoplasmic labile iron. Upon mitochondrial complex I inhibition, DHC12 protected plasma membrane and mitochondria against lipid peroxidation, as detected by the reduced formation of 4-hydroxynonenal adducts and oxidation of C11-BODIPY 581/591 . DHC12 also blocked the decrease in mitochondrial membrane potential, detected by tetramethylrhodamine distribution. DHC12 inhibited MAO-A and MAO-B activity. Oral administration of DHC12 to mice (0.25 mg/kg body weight) protected substantia nigra pars compacta (SNpc) neurons against MPTP-induced death. Taken together, our results support the concept that DHC12 is a mitochondrial-targeted neuroprotective iron–copper chelator and MAO-B inhibitor with potent antioxidant and mitochondria protective activities. Oral administration of low doses of DHC12 is a promising therapeutic strategy for the treatment of diseases with a mitochondrial iron accumulation component, such as PD. Graphic Abstract


  • 주제어

    Neurodegeneration with brain iron accumulation .   coumarin-based iron−copper chelator .   antioxidant .   Parkinson;s disease .   MPTP mouse model .   neuroprotection.  

 활용도 분석

  • 상세보기

    amChart 영역
  • 원문보기

    amChart 영역

원문보기

무료다운로드
  • 원문이 없습니다.
유료다운로드

유료 다운로드의 경우 해당 사이트의 정책에 따라 신규 회원가입, 로그인, 유료 구매 등이 필요할 수 있습니다. 해당 사이트에서 발생하는 귀하의 모든 정보활동은 NDSL의 서비스 정책과 무관합니다.

원문복사신청을 하시면, 일부 해외 인쇄학술지의 경우 외국학술지지원센터(FRIC)에서
무료 원문복사 서비스를 제공합니다.

NDSL에서는 해당 원문을 복사서비스하고 있습니다. 위의 원문복사신청 또는 장바구니 담기를 통하여 원문복사서비스 이용이 가능합니다.

이 논문과 함께 출판된 논문 + 더보기